Literature DB >> 21731529

A targeted maximum likelihood estimator of a causal effect on a bounded continuous outcome.

Susan Gruber1, Mark J van der Laan.   

Abstract

Targeted maximum likelihood estimation of a parameter of a data generating distribution, known to be an element of a semi-parametric model, involves constructing a parametric model through an initial density estimator with parameter ɛ representing an amount of fluctuation of the initial density estimator, where the score of this fluctuation model at ɛ = 0 equals the efficient influence curve/canonical gradient. The latter constraint can be satisfied by many parametric fluctuation models since it represents only a local constraint of its behavior at zero fluctuation. However, it is very important that the fluctuations stay within the semi-parametric model for the observed data distribution, even if the parameter can be defined on fluctuations that fall outside the assumed observed data model. In particular, in the context of sparse data, by which we mean situations where the Fisher information is low, a violation of this property can heavily affect the performance of the estimator. This paper presents a fluctuation approach that guarantees the fluctuated density estimator remains inside the bounds of the data model. We demonstrate this in the context of estimation of a causal effect of a binary treatment on a continuous outcome that is bounded. It results in a targeted maximum likelihood estimator that inherently respects known bounds, and consequently is more robust in sparse data situations than the targeted MLE using a naive fluctuation model. When an estimation procedure incorporates weights, observations having large weights relative to the rest heavily influence the point estimate and inflate the variance. Truncating these weights is a common approach to reducing the variance, but it can also introduce bias into the estimate. We present an alternative targeted maximum likelihood estimation (TMLE) approach that dampens the effect of these heavily weighted observations. As a substitution estimator, TMLE respects the global constraints of the observed data model. For example, when outcomes are binary, a fluctuation of an initial density estimate on the logit scale constrains predicted probabilities to be between 0 and 1. This inherent enforcement of bounds has been extended to continuous outcomes. Simulation study results indicate that this approach is on a par with, and many times superior to, fluctuating on the linear scale, and in particular is more robust when there is sparsity in the data.

Keywords:  TMLE; causal effect; targeted maximum likelihood estimation

Mesh:

Year:  2010        PMID: 21731529      PMCID: PMC3126669          DOI: 10.2202/1557-4679.1260

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  4 in total

1.  Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

Authors:  M A Hernán; B Brumback; J M Robins
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Collaborative targeted maximum likelihood for time to event data.

Authors:  Ori M Stitelman; Mark J van der Laan
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

3.  Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods.

Authors:  Thérèse A Stukel; Elliott S Fisher; David E Wennberg; David A Alter; Daniel J Gottlieb; Marian J Vermeulen
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

4.  Super learner.

Authors:  Mark J van der Laan; Eric C Polley; Alan E Hubbard
Journal:  Stat Appl Genet Mol Biol       Date:  2007-09-16
  4 in total
  46 in total

1.  Targeted maximum likelihood estimation of natural direct effects.

Authors:  Wenjing Zheng; Mark J van der Laan
Journal:  Int J Biostat       Date:  2012-01-06       Impact factor: 0.968

2.  The relative performance of targeted maximum likelihood estimators.

Authors:  Kristin E Porter; Susan Gruber; Mark J van der Laan; Jasjeet S Sekhon
Journal:  Int J Biostat       Date:  2011-08-17       Impact factor: 0.968

3.  Adaptive pre-specification in randomized trials with and without pair-matching.

Authors:  Laura B Balzer; Mark J van der Laan; Maya L Petersen
Journal:  Stat Med       Date:  2016-07-19       Impact factor: 2.373

4.  Introduction to Double Robust Methods for Incomplete Data.

Authors:  Shaun R Seaman; Stijn Vansteelandt
Journal:  Stat Sci       Date:  2018       Impact factor: 2.901

5.  Targeted maximum likelihood estimation of effect modification parameters in survival analysis.

Authors:  Ori M Stitelman; C William Wester; Victor De Gruttola; Mark J van der Laan
Journal:  Int J Biostat       Date:  2011-03-30       Impact factor: 0.968

6.  A targeted maximum likelihood estimator for two-stage designs.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2011-03-11       Impact factor: 0.968

7.  An application of collaborative targeted maximum likelihood estimation in causal inference and genomics.

Authors:  Susan Gruber; Mark J van der Laan
Journal:  Int J Biostat       Date:  2010-05-17       Impact factor: 0.968

8.  An educational intervention to improve knowledge about prevention against occupational asthma and allergies using targeted maximum likelihood estimation.

Authors:  Daloha Rodríguez-Molina; Swaantje Barth; Ronald Herrera; Constanze Rossmann; Katja Radon; Veronika Karnowski
Journal:  Int Arch Occup Environ Health       Date:  2019-01-14       Impact factor: 3.015

9.  Estimating the Effect of a Community-Based Intervention with Two Communities.

Authors:  Mark J van der Laan; Maya Petersen; Wenjing Zheng
Journal:  J Causal Inference       Date:  2013-05

10.  Discussion of Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer, by Wang et al. 2012.

Authors:  Paul Chaffee; Mark van der Laan
Journal:  J Am Stat Assoc       Date:  2012-07-24       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.